AAP
AGN

Arax Advisory Partners’s Allergan plc AGN Stock Holding History

Arax Advisory Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21
Closed -$4K – 723
2020
Q1 		$4K Sell
21
-26
-55% -$4.9K ﹤0.01% 594
2019
Q4 		$9K Hold
47
– – ﹤0.01% 481
2019
Q3 		$8K Hold
47
– – ﹤0.01% 484
2019
Q2 		$8K Buy
+47
New +$6.51K ﹤0.01% 487
2018
Q4 		$6K Hold
46
– – ﹤0.01% 483
2018
Q3 		$9K Sell
46
-143
-76% -$26.3K ﹤0.01% 483
2018
Q2 		$31K Sell
189
-119
-39% -$19.1K 0.01% 267
2018
Q1 		$51K Buy
308
+263
+584% +$44.1K 0.03% 201
2017
Q4 		$7K Sell
45
-282
-86% -$50.6K ﹤0.01% 350
2017
Q3 		$67K Buy
327
+74
+29% +$17.2K 0.03% 184
2017
Q2 		$62K Sell
253
-68
-21% -$16K 0.03% 208
2017
Q1 		$76K Buy
321
+92
+40% +$21.4K 0.04% 155
2016
Q4 		$48K Buy
+229
New +$47.4K 0.02% 173

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Arax Advisory Partners's AGN Position: Q2 2020 in Review

Arax Advisory Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21 shares — an estimated $4K sold.

Arax Advisory Partners first reported a position in AGN in Q4 2016 and held it in 13 quarters. The position peaked at $76K in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Arax Advisory Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Arax Advisory Partners sold 21 Allergan plc shares in Q2 2020, an estimated $4K.
  • Arax Advisory Partners first reported a position in Allergan plc in Q4 2016 and held it in 13 quarters.
  • Arax Advisory Partners's Allergan plc position peaked at $76K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Arax Advisory Partners's 13F filing for Q2 2020, filed 6 Aug 2020.